Latest News
-

Should we worry about a huntingtin invasion?
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
-

EuroBuzz 2014 Video, day one
Video of our first live session at the European Huntington's Disease Network Meeting.
-

EuroBuzz 2014 Video, day two
Video of our second live session at the European Huntington's Disease Network Meeting.
-

Melatonin alterations in Huntington's disease help explain trouble with sleep
Study shows HD patients have decreased levels of melatonin, which may explain why so many suffer from sleep problems
-

EuroBuzz 2014: day three
Our third and final report on the 2014 European Huntington's Disease Network meeting in Barcelona
-

EuroBuzz 2014: day two
HDBuzz reports on the second day of science at the European HD Network meeting in Barcelona
-

EuroBuzz 2014: day one
Highlights from the opening day of the 2014 European Huntington's Disease network in Barcelona, Spain
-

Going toe-to-toe with tau: new insights into the chemical basis of Huntington’s disease
Does tau protein – which causes problems in other neurodegenerative diseases – contribute to Huntington's disease?
-

New results bring BDNF therapies into focus
Some unexpected findings suggest new ways to aim at an old target in HD
-

2CARE study of coenzyme Q for Huntington's disease ends in disappointment
The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial
Previously featured
-
Putting it in print: oral drug branaplam lowered huntingtin, but safety concerns halted development
-
A hitch in the stitch reveals why DNA sequence patterns matter in Huntington’s disease
-
Worms to the Rescue: Separating the Good, the Bad, and the Clumpy Huntingtin
-
January 2026: This Month in Huntington’s Disease Research
-
Phase 1 results announced for Skyhawk’s drug SKY-0515
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
